Relationship between resilience and mental health among COVID-19 bereaved people: the mediating role of dual process coping [0.03%]
新冠肺炎丧亲者的心理韧性与心理健康关系：双过程应对的中介作用研究
Liping Wu,Siying Chen,Suqin Tang
Liping Wu
Background: People bereaved due to COVID-19 may face mental health challenges and posttraumatic growth opportunities. Resilience, as an inherent trait or ability, may protect the bereaved from developing mental health pro...
Decreased citalopram concentration caused by enzyme induction effect of rifampin: a case report [0.03%]
利福平的酶诱导作用导致西酞普兰浓度降低一例报告
Jiajia Liu,Jinmeng Li,Ren Zheng et al.
Jiajia Liu et al.
Citalopram is a selective serotonin reuptake inhibitor used to treat depression and various anxiety disorders, which is mainly metabolized by the P450 (CYP) enzyme. Rifampin is a rifamycin with bactericidal activity against Mycobacterium tu...
Sofia Pappa,Robin Emsley
Sofia Pappa
Clozapine/norclozapine plasma level ratio and cognitive functioning in patients with schizophrenia spectrum disorders: a systematic review [0.03%]
精神分裂症谱系障碍患者氯氮平/脱氢氯氮平血浆浓度比值与其认知功能系统综述研究
Timo T Moscou,Selene R T Veerman
Timo T Moscou
Background: Extant research on cognitive functioning in treatment-resistant schizophrenia (TRS) is limited and of poor quality. Cognitive impairments in patients with schizophrenia spectrum disorders (SSD) significantly i...
Disrupted emotion regulation and spontaneous neural activity in panic disorder: a resting-state fMRI study [0.03%]
恐慌障碍下的情绪调节紊乱及自发性脑活动：静息态功能磁共振成像研究
Hai-Yang Wang,Bei-Yan Guan,Shi-Yao Wang et al.
Hai-Yang Wang et al.
Background: Emotional dysregulation, particularly unconscious catastrophic cognitions, plays a pivotal role in the genesis of panic disorder (PD). However, no studies have yet applied the percentage of amplitude fluctuati...
Prevalence and risk factors of PTSD symptoms: a 3-month follow-up study [0.03%]
PTSD症状的流行率及影响因素：3个月随访研究
Zhilei Shang,Xiao Pan,Suhui Cheng et al.
Zhilei Shang et al.
Background: During the peak of the epidemic, hospitalized patients frequently encountered significant health risks and potentially life-threatening circumstances, including uncertainty regarding treatment and the potentia...
Plain Language Summary of Publication: A comparison of once-monthly and once-every-2-months injectable formulations of aripiprazole in people with schizophrenia [0.03%]
摘要：阿立哌唑一个月一次与两个月一次的长效制剂在精神分裂症患者中的比较
Leslie Citrome,Pedro Such,Murat Yildirim et al.
Leslie Citrome et al.
The purpose of this summary is to explain key findings from a study that included people with schizophrenia, as described in two separate articles (see the 'Further Information' section for more details). The study compared a new formulatio...
Use of an injection of aripiprazole given once every 2 months (Abilify Asimtufii®) in people with bipolar I disorder: a Plain Language Summary of Publication [0.03%]
用于治疗双相情感障碍Ⅰ型患者的长效针剂阿立哌唑（艾米替尤）每月一次注射的疗效：发布文件通俗易懂版本
Roger S McIntyre,Pedro Such,Murat Yildirim et al.
Roger S McIntyre et al.
The purpose of this summary is to explain key findings from a study that included people with bipolar I disorder, as described in two separate articles (see the 'Further Information' section for more details). The study compared a new formu...
Risperidone ISM®: review and update of its usefulness in all phases of schizophrenia [0.03%]
利培酮ISM的临床应用：综述与更新——治疗精神分裂症各期的有效性
Thomas Messer,Miquel Bernardo,Lourdes Anta et al.
Thomas Messer et al.
One of the most important challenges in the management of patients with schizophrenia is to ensure adherence to antipsychotic treatment. The contribution of long-acting injectables (LAI) is undeniable in this matter, but there are still som...